Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
Por um escritor misterioso
Descrição
Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]
Effect of body mass index on treatment response of biologic
PDF) Development and preselection of criteria for short term
PDF) Impact of Secukinumab on Patient-Reported Outcomes in the
ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response
Full article: ABSTRACTS OF THE 38TH SCANDINAVIAN CONGRESS OF
PDF) AB0002 Sirt-1 Activity in PBMC from Patients with
Full article: POSTER PRESENTATIONS
Efficacy and Safety of Tofacitinib in Patients with Ankylosing
PDF) Multi-biomarker disease activity score as a predictor of
Efficacy of a tight-control and treat-to-target strategy in axial
Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update
de
por adulto (o preço varia de acordo com o tamanho do grupo)
